Bolak Co

Bolak Co EBIT per Employee

The EBIT per Employee of Bolak Co (002760.KS) as of Oct 30, 2026 is 16.28 M KRW. In the previous year, EBIT per Employee was -13.08 M KRW — a change of -224.46% (higher).

EBIT per Employee

16.28 MKRW

YoY

-224.46%

Last updated:

EBIT per Employee of Bolak Co is 2025 16.28 M KRW. EBIT per Employee of Bolak Co was 2024 -13.08 M KRW. It decreases by -224.46% higher compared to the previous year.

The Bolak Co EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
9.65 M KRW
Jan 1, 2019
5.04 M KRW
Jan 1, 2020
2.53 M KRW
Jan 1, 2021
13.90 M KRW
Jan 1, 2022
25.03 M KRW
Jan 1, 2023
5.73 M KRW
Jan 1, 2024
-13.08 M KRW
Jan 1, 2025
16.28 M KRW
The Bolak Co EBIT per Employee history
YEAREBIT per EmployeeYoY
16.28 MKRW-224.46%
-13.08 MKRW-328.39%
5.73 MKRW-77.12%
25.03 MKRW+80.04%
13.90 MKRW+449.71%
2.53 MKRW-49.83%
5.04 MKRW-47.76%
9.65 MKRW+3.35%
9.34 MKRW-37.03%
14.83 MKRW+58.75%
9.34 MKRW-37.41%
14.92 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bolak Co Stock analysis

What does Bolak Co do? Bolak Co., Ltd. generates revenue through its two core business divisions: food additives and pharmaceutical ingredients. The food additives division produces flavors, colors, botanical extracts, nutraceuticals, white emulsion, antioxidants, emulsifiers, bleaching agents, acidulant, and sweetness products. The pharmaceutical ingredients division manufactures extract powers, fluid extracts, tinctures, protein concentrates, and calcium carboxymethyl cellulose (CMC). Domestic and overseas markets purchase these products, with the company distributing them across both regions. The firm's product portfolio targets food manufacturers and pharmaceutical companies seeking raw materials for their production processes. Bolak Co., Ltd. serves food manufacturers and pharmaceutical companies as its primary customer segments. These segments require specialized ingredients for their product development and production lines. The company's domestic market includes Korean food and pharma firms, while overseas buyers include international food processors and pharmaceutical producers. The firm's product range supports both the food and pharmaceutical industries through direct sales to these end-users. The company's revenue streams are derived from the sale of its manufactured ingredients, with no mention of additional services or licensing. Food additives like white emulsion and antioxidants are sold to food producers, while pharmaceutical ingredients such as protein concentrates and CMC are supplied to drug manufacturers. The business model relies on consistent demand for these raw materials from established industry clients. Bolak Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bolak Co stock

EBIT per Employee of Bolak Co is 16.28 M KRW in 2025.

EBIT per Employee of Bolak Co changed from -13.08 M KRW to 16.28 M KRW, representing a -224.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Bolak Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Bolak Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Bolak Co

All Key Metrics — Bolak Co